India, Aug. 17 -- Today's after-hours gainers included Profusa, following its latest reverse stock split; INVO Fertility, after reporting second-quarter financial results; Vogenx, which recently made its Nasdaq debut; and Amylyx Pharmaceuticals, whose shares climbed ahead of the company's Phase 3 LUCIDITY topline results for Avexitide in post-bariatric hypoglycemia, scheduled for release on August 18, 2026.
Read on...
Profusa Inc. (PFSA) implemented a 1-for-4 reverse stock split on Monday, following its 1-for-25 reverse stock split completed on July 7, 2026.
As a result of Monday's reverse stock split, the number of shares of common stock outstanding will be reduced from 2,422,906 shares to approximately 605,726 shares, and the number of...